Innoviva (INVA) Change in Cash (2010 - 2026)
Innoviva (INVA) posted Change in Cash of $52.1 million for Q1 2026, down 69.6% on a QoQ basis from $171.5 million in Q3 2025, and up 269.13% year-over-year from $14.1 million in Q1 2025.
Innoviva (INVA) Change in Cash (2010 - 2026) Analysis & Trends
Innoviva's Change in Cash history runs 17 years deep, the most recent figure standing at $52.1 million for Q1 2026.
- Quarterly Change in Cash rose 269.13% year-over-year to $52.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $316.3 million (up 201.97% YoY) and the FY2025 annual result came in at $246.0 million, up 120.7% from the prior year.
- Change in Cash was $52.1 million for Q1 2026 at Innoviva, down from $171.5 million in the prior quarter.
- Across five years, Change in Cash topped out at $171.5 million in Q3 2025 and bottomed at -$147.0 million in Q1 2023.
- A 5-year average of $27.6 million and a median of $38.6 million in 2024 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2023 — Change in Cash slumped 1062.23% — and 2026, when it jumped 269.13%.
- Innoviva's Change in Cash stood at $99.3 million in 2022, then plunged by 211.83% to -$111.1 million in 2023, then jumped by 160.44% to $67.1 million in 2024, then surged by 155.6% to $171.5 million in 2025, then tumbled by 69.6% to $52.1 million in 2026.
- Business Quant data shows INVA's Change in Cash at $52.1 million in Q1 2026, $171.5 million in Q3 2025, and $78.4 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -22.03 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 243.78 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 417.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -153.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Innoviva | 1.57 Bn | 969.11 Mn | 75.83 Mn | 52.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 52.14 Mn |
| Sep 30, 2025 | 171.55 Mn |
| Jun 30, 2025 | 78.44 Mn |
| Mar 31, 2025 | 14.13 Mn |
| Sep 30, 2024 | 67.12 Mn |
| Jun 30, 2024 | 38.65 Mn |
| Mar 31, 2024 | -15.16 Mn |
| Sep 30, 2023 | -111.05 Mn |
| Jun 30, 2023 | 28.98 Mn |
| Mar 31, 2023 | -147.00 Mn |
| Sep 30, 2022 | 99.30 Mn |
| Jun 30, 2022 | 66.78 Mn |
| Mar 31, 2022 | 15.28 Mn |
| Sep 30, 2021 | -111.37 Mn |
| Jun 30, 2021 | -239.63 Mn |
| Mar 31, 2021 | 36.40 Mn |
| Dec 31, 2020 | -232.71 Mn |
| Sep 30, 2020 | 66.05 Mn |
| Jun 30, 2020 | 61.17 Mn |
| Mar 31, 2020 | 73.89 Mn |